Last updated on December 2019

A Study to Assess the Safety Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis


Brief description of study

This is a study to evaluate the long-term safety and tolerability of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (PSO).

Clinical Study Identifier: NCT03598790

Find a site near you

Start Over

Ps0014 627

Itabashi-Ku, Japan
3.4miles
  Connect »

Ps0014 608

Itabashi-Ku, Japan
3.41miles
  Connect »

Ps0014 612

Shinjuku-Ku, Japan
4.09miles
  Connect »

Ps0014 626

Shinjuku-Ku, Japan
4.09miles
  Connect »

Ps0014 618

Shinjuku-Ku, Japan
4.1miles
  Connect »

Ps0014 605

Bunkyo-Ku, Japan
5.97miles
  Connect »

Ps0014 607

Chiyoda-Ku, Japan
6.4miles
  Connect »

Ps0014 604

Minato-Ku, Japan
7.76miles
  Connect »

Ps0014 610

Chuo Ku, Japan
8.11miles
  Connect »

Ps0014 615

Sumida-Ku, Japan
8.59miles
  Connect »

Ps0014 602

Shinagawa-Ku, Japan
9.79miles
  Connect »